Krystal Biotech Inc (KRYS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | KRYS | HALO | KYMR | ||
| Company | Krystal Biotech Inc | Halozyme Therapeutic | Kymera Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 260.97 | 65.14 | 84.20 | ||
| High | 264.00 | 66.00 | 86.78 | ||
| Low | 255.48 | 64.46 | 83.61 | ||
| Latest | 258.91 | 65.40 | 84.93 | ||
| Change | +0.59 | +0.77 | +1.64 | ||
| % Change | +0.23% | +1.19% | +1.97% | ||
| Volume | 351,200 | 1,762,100 | 668,100 | ||
| 20-Day Average Volume | 290,235 | 1,536,920 | 692,270 | ||
| Previous Close | 258.32 | 64.63 | 83.29 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 253.37 | 64.47 | 80.42 | ||
| 20-Day Raw Stochastic | 71.50% | 49.79% | 85.38% | ||
| 20-Day Relative Strength | 50.51 | 45.84 | 55.67 | ||
| Weighted Alpha | +62.60 | +6.90 | +124.07 | ||
| Today's Opinion | 56% Buy | 24% Sell | 72% Buy | ||
| Previous Opinion | 56% Buy | 40% Sell | 88% Buy | ||
| Last Month's Opinion | 64% Buy | 24% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.55% since 03/25/26 | +3.42% since 03/25/26 | +7.60% since 03/25/26 | ||
| Low | 242.00 on 03/31/26 | 61.33 on 03/27/26 | 77.24 on 03/26/26 | ||
| High | 264.00 on 04/01/26 | 66.00 on 04/01/26 | 86.78 on 04/01/26 | ||
| 1-Month | |||||
| %Chg | -6.07% since 02/27/26 | -5.94% since 02/27/26 | -7.03% since 02/27/26 | ||
| Low | 242.00 on 03/31/26 | 61.33 on 03/27/26 | 73.31 on 03/24/26 | ||
| High | 270.00 on 03/02/26 | 71.53 on 03/04/26 | 91.00 on 03/02/26 | ||
| 3-Month | |||||
| %Chg | +5.02% since 12/31/25 | -2.82% since 12/31/25 | +9.15% since 12/31/25 | ||
| Low | 235.60 on 01/05/26 | 61.33 on 03/27/26 | 66.21 on 01/20/26 | ||
| High | 298.30 on 02/17/26 | 82.22 on 02/09/26 | 95.90 on 02/26/26 | ||
| 6-Month | |||||
| %Chg | +44.15% since 10/01/25 | -12.73% since 10/01/25 | +55.38% since 10/01/25 | ||
| Low | 178.61 on 10/02/25 | 61.22 on 12/11/25 | 54.35 on 10/02/25 | ||
| High | 298.30 on 02/17/26 | 82.22 on 02/09/26 | 103.00 on 12/08/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 7,551,211 | 7,656,974 | 6,799,961 | ||
| Shares Outstanding, K | 29,232 | 118,474 | 81,642 | ||
| Annual Sales | 389,130,000 | 1,396,610,000 | 39,210,000 | ||
| Annual Net Income | 204,830,000 | 316,890,000 | -311,350,000 | ||
| Last Quarter Sales | 107,110,000 | 451,770,000 | 2,870,000 | ||
| Last Quarter Net Income | 51,400,000 | -141,590,000 | -86,980,000 | ||
| 60-Month Beta | 0.49 | 0.98 | 2.20 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.70 on 02/17/26 | -0.24 on 02/17/26 | -0.97 on 02/26/26 | ||
| Latest Earnings Date | 05/05/26 | 05/05/26 | 05/08/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 36.05 | 16.44 | 0.00 | ||